cbdMD, Inc. (YCBD-PA)

USD 0.68

(1.49%)

Operating Income Summary of cbdMD, Inc.

cbdMD, Inc.'s latest annual operating income in 2023 was -9.26 Million USD , down -162.8% from previous year.
cbdMD, Inc.'s latest quarterly operating income in 2024 Q3 was -382.03 Thousand USD , up 75.37% from previous quarter.
cbdMD, Inc. reported an annual operating income of 35.8 Million USD in 2022, up 282.54% from previous year.
cbdMD, Inc. reported an annual operating income of -19.61 Million USD in 2021, down -11.57% from previous year.
cbdMD, Inc. reported a quarterly operating income of -1.55 Million USD for 2024 Q2, down -55.37% from previous quarter.
cbdMD, Inc. reported a quarterly operating income of -382.03 Thousand USD for 2024 Q3, up 75.37% from previous quarter.

Annual Operating Income Chart of cbdMD, Inc. (2023 - 2016)

Historical Annual Operating Income of cbdMD, Inc. (2023 - 2016)

Year	Operating Income	Operating Income Growth
2023	-9.26 Million USD	-162.8%
2022	35.8 Million USD	282.54%
2021	-19.61 Million USD	-11.57%
2020	-17.58 Million USD	-191.84%
2019	19.14 Million USD	16247.89%
2018	117.09 Thousand USD	148.94%
2017	-239.29 Thousand USD	93.59%
2016	-3.73 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-998.24 Thousand USD	93.44%
2024 Q2	-1.55 Million USD	-55.37%
2024 Q3	-382.03 Thousand USD	75.37%
2023 Q4	-15.21 Million USD	-734.43%
2023 Q3	-1.82 Million USD	-30.2%
2023 FY	-22.48 Million USD	-162.8%
2023 Q1	-4.04 Million USD	73.0%
2023 Q2	-1.4 Million USD	65.38%
2022 Q2	-5.01 Million USD	80.07%
2022 Q4	-14.98 Million USD	-537.53%
2022 FY	35.8 Million USD	282.54%
2022 Q1	-25.14 Million USD	-258.56%
2022 Q3	-2.35 Million USD	53.09%
2021 Q1	-1.75 Million USD	61.16%
2021 Q2	-4.16 Million USD	-136.81%
2021 FY	-19.61 Million USD	-11.57%
2021 Q4	-7.01 Million USD	-5.05%
2021 Q3	-6.67 Million USD	-60.17%
2020 Q2	-5.6 Million USD	8.37%
2020 Q1	-6.11 Million USD	-80.66%
2020 FY	-17.58 Million USD	-191.84%
2020 Q4	-4.53 Million USD	-238.77%
2020 Q3	-1.33 Million USD	76.12%
2019 Q1	-787.09 Thousand USD	12.77%
2019 FY	19.14 Million USD	16247.89%
2019 Q4	-3.38 Million USD	59.04%
2019 Q3	-8.26 Million USD	-244.08%
2019 Q2	-2.4 Million USD	-205.0%
2018 Q1	-1.22 Million USD	-345.68%
2018 Q2	1.61 Million USD	231.92%
2018 Q3	627.48 Thousand USD	-61.27%
2018 Q4	-902.33 Thousand USD	-243.8%
2018 FY	117.09 Thousand USD	148.94%
2017 FY	-239.29 Thousand USD	93.59%
2017 Q1	-563.17 Thousand USD	45.31%
2017 Q2	-72.49 Thousand USD	87.13%
2017 Q3	671.91 Thousand USD	1026.8%
2017 Q4	-275.53 Thousand USD	-141.01%
2016 Q3	-1.42 Million USD	0.0%
2016 Q4	-1.02 Million USD	27.57%
2016 FY	-3.73 Million USD	0.0%

Peer Operating Income Comparison of cbdMD, Inc.

Name	Operating Income	Operating Income Difference
China Pharma Holdings, Inc.	-2.75 Million USD	-236.815%
cbdMD, Inc.	-9.26 Million USD	-0.0%
Zomedica Corp.	-31.59 Million USD	70.662%